Decreased survival and increased rate of fibrotic progression in essential thrombocythemia chronicled after the FDA approval date of anagrelide

American Journal of Hematology,Volume 0, Issue ja, -Not available-.

Source: American Journal of Hematology - September 25, 2018 Category: Hematology Authors: Ayalew Tefferi, Natasha Szuber, Rangit R. Vallapureddy, Kebede H. Begna, Mrinal M. Patnaik, Michelle A. Elliott, C. Christopher Hook, Alexandra P. Wolanskyj, Curtis A. Hanson, Rhett P. Ketterling, Animesh Pardanani, Naseema Gangat Source Type: research